Locations
San Francisco, CA, USA · Sunnyvale, CA, USA
industry
Biotechnology
Size
11-50 employees
Stage
Series A
founded in
2021
MIXCR is an ultimate software platform for analysis of Next-Generation Sequencing (NGS) data for immune profiling. It’s widely used to empower R&D in vaccine development, CAR-T therapies, antibody discovery, and other areas. Eight out of ten big pharma companies choose MIXCR for studying the immune system. Aiming to support non-profit research, we provide MIXCR for free for academic and non-commercial use. For years, MIXCR has been the number one solution for immune system studies in academia and industry.
Is this your company?
Something looks off?